Table 1.
Patients' characteristics.
| Transient controllers |
Persistent controllers |
p-Value | |
|---|---|---|---|
| TC (n = 8) | PC (n = 8) | ||
| Age (years) | 41 [34–60] | 44 [40–46] | 0·635 |
| Male sex, n (%) | 5 (62.5) | 4 (50) | 0·614 |
| IDU, n (%) | 3 (37.5) | 4 (50) | 0·198 |
| Time since diagnosis (years) | 3 [2–8] | 13 [10–17] | 0·005 |
| HCV RNA detected, n (%) | 3 (37·5) | 3 (37·5) | 0·999 |
| CD4+ T-cells (cell/μL) | 676 [623–963] | 724 [609–985] | 0·817 |
| CD8+ T-cells (cell/μL) | 787 [553–1162] | 636 [432–1026] | 0·482 |
| CD4:CD8 Ratio | 0.86 [0·53–1·55] | 1.08 [0·93–1·47] | 0·406 |
Values from TC are taken from –T2 and values from PC are taken from the first follow-up time point. Values are given as percentage for categorical variables or median and interquartile range for continous variables. The Mann-Whitney U and Chi-squared tests were used. All p values <0·05 were considered significant and are highlighted in bold. IDU, Intravenous drug users.